SMA Capital LLC

Position in ALKS — Alkermes plc.

CIK 2075338 NEW YORK, NY

Position in ALKS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,375

New position

Shares Held

198

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#357

of 421 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SMA Capital LLC holds $52,306 across 4 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	122	$20,561
2	INDV	Indivior Pharmaceuticals, Inc.	276	$11,324
3	ALKS	Alkermes plc. This page	198	$10,375
4	SUPN	Supernus Pharmaceuticals, Inc.	216	$10,046

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,375	198	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.